Clinical trial · Observational
Inflammatory Biomarkers in Psychogenic Non-epileptic Seizure
Possible Role of Inflammatory Serum Biomarkers in Differentiation Between Epileptic Seizure and Psychogenic Non-epileptic Seizure
NCT05571371CI-TRIAL-00061304seizureunknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
1. Evaluation of the role of TRAIL and MCP-2 in differentiation between epileptic seizure and psychogenic non-epileptic seizure. 2. Possible role to predict the prognosis of patients with epileptic seizure.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Localization-Related (Focal) (Partial) Idiopathic Epilepsy and Epileptic Syndromes With Seizures of Localized Onset | — | UNRESOLVED | — |
| MCP-2: Monocyte Chemo-attractant Protein-2 | — | UNRESOLVED | — |
| TRAIL: Tumor Necrosis Factor Related Apoptosis Inducing Ligand MCP-2 | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Measuring inflammatory serum biomarkers | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Epileptic seizure
- description
- Measuring inflammatory serum biomarkers in epileptic seizure patients and psychogenic non-epileptic seizure
- interventionNames
- Other: Measuring inflammatory serum biomarkers
Primary outcomes (2)
- measure
- 1- Evaluation of the role of TRAIL and MCP-2 in differentiation between epileptic seizure and psychogenic non-epileptic seizure
- timeFrame
- in first 24 hours of seizure
- description
- Measurement of TRAIL and MCP-2 in differentiation between epileptic seizure and psychogenic non-epileptic seizure.
- measure
- 2- Possible role to predict the prognosis of patients with epileptic seizure.
- timeFrame
- in first 24 hours of seizure
- description
- Differentiation between epileptic seizure and psychogenic non-epileptic seizure help in diagnosis and predict prognosis of seizure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 12 Years
Show eligibility criteria text
Inclusion Criteria:
* patients diagnosed as epileptic seizure are aged \>12 years patients diagnosed as psychogenic non-epileptic seizure are aged \>12 years Normal healthy control for comparison. Heathy control are aged \>12 years with no history of lifetime seizures or suspected seizures or febrile seizure and no treatment with an antiepileptic drug (AED) prior to blood draw
Exclusion Criteria:
* Neurological criteria: Other CNS disorders including Parkinson's disease, amyotrophic lateral sclerosis ,cerebrovascular stroke, Psychiatric disorders {major depression disorder , generalized anxiety, mania and other psychiatric diseases).
Others: Tumors and cardiovascularReferences
Publications (0)
Data not yet available
No reference posted for this study.